TOPIC

Biomedicine: Companies

Related Topics:
Biomedicine: Companies
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
last updated:
12 December, 2024
Riad Sherif, CEO of Oculis Holding, says the high prevalence of diabetic macular edema in Hong Kong is partly due to an ageing population. Photo: May Tse
New medical drugs

Novel drug awaits Hong Kong diabetics suffering from debilitating eye disease

Oculis’ OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says.

videocam
Wuxi AppTec

WuXi AppTec, WuXi Biologics surge on slimmer chances of Biosecure Act’s passage

Biomedicine: Science

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds

Biomedicine: Industry Trends

China welcomes new US$1 billion Sanofi project in Beijing

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi said the new plant in Beijing will be its fourth such facility on the mainland. Photo: Shutterstock
Biomedicine: Science

Hong Kong start-up eyes global pest control market with scent-based products

Plasticvore is a two-year old biotech start-up offering alternative, humane solutions to controlling and eliminating pests, founder says.

videocam
Health & Fitness

China expands health insurance coverage with 91 new drugs, innovative treatments

The health authority shows its support for novel drugs, while driving tough bargains with pharmaceutical firms on prices.

videocam
Advertisement
Advertisement
SCMP Highlights

Recap | ‘Promising’ steps to HIV vaccine, Trump tariffs threaten profits: 5 biotech stories

Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories.

A Hong Kong biotech start-up says its first-phase trial of a therapeutic HIV vaccine has shown promising results. Photo: dpa
Biomedicine: Geopolitics

Chinese biotech firms brace for Trump tariffs, US funding bill

Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.

Hong Kong

Vaccine shows promise in curing HIV, Hong Kong start-up says

‘We may be on the brink of a breakthrough,’ Dr Edward Leong, advisory board chairman of Immuno Cure says.

Biomedicine: Science

Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs

BioNTech says deal will support its push into the development of cancer drugs using its proven mRNA technology.

Ugur Sahin, CEO and co-founder of BioNTech. Photo: Reuters
Science

Opinion | Why a new approach to diabetes treatment is desperately needed

Current widely used treatment approaches are not fit for task as they ignore the idiosyncrasies in diabetes that can arise in each patient.

videocam
A diabetes patient injecting insulin in their abdomen. The International Diabetes Foundation estimates almost 540 million adults had diabetes in 2020. Photo: Shutterstock
Health in China

Chinese pharmaceutical companies look abroad for growth markets

Shanghai Henlius struck a deal in Saudi Arabia while XtalPi signed a partnership with Sinar Mas Multiartha in Indonesia.

Greater Bay Area

Hong Kong health-tech start-ups create digital wearables for seniors

With a regulatory approach that expands the market for such devices to the Greater Bay Area, local companies see opportunity for growth.

videocam
Coronavirus vaccine

AstraZeneca’s China president under ‘ongoing investigation’: company

Drug maker has yet to elaborate whether Leon Wang is in custody, nor have his whereabouts been disclosed.

Leon Wang, AstraZeneca’s China president, speaks at an event in Hong Kong in November 2023. Photo: Jelly Tse
FII conference

Hong Kong start-ups eye Middle East capital under new accord with venture fund

Start-ups with expertise in artificial intelligence, biotech and green energy can contribute to Saudi Arabia’s economic diversification agenda.

5
HKSTP CEO Albert Wong Hak-keung (seated, right) signs the agreement with Beta Lab founder Abdulrahman Alolayan in Riyadh on October 29. Photo: Enoch Yiu
Biomedicine: Industry Trends

Hong Kong health tech: private-public alliance advances male HPV testing

Neo-Health Group says its device, developed with a government-backed research institute, will also help test for skin infections and cancers.

Cancer

CK Life’s Yuen banks on Big Pharma experience to boost new drug success

Lance Yuen spent two decades at Bristol-Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.

Advertisement
Advertisement
Wuxi AppTec

WuXi AppTec, WuXi Biologics rise in Hong Kong as some operations go up for sale

The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened US scrutiny.

The reported divestment plans of WuXi AppTec and WuXi Biologics show their efforts to head off the potential impact of the US Biosecure Act. Photo: Shutterstock
China stock market

Wuxi AppTec’s upbeat business update boosts stock despite US bill

A presentation persuaded investors that risk of a potential US blacklisting is low while growth in some business areas is ‘unprecedented’.

Health & Fitness

Ultrasound cancer treatment, supported by Li Ka-shing, gains traction in Asia

Focused ultrasound, backed by Li Ka-shing, is emerging as a non-invasive, commercially viable cancer treatment, attracting significant investments.

videocam
Business of climate change

Hong Kong’s advanced materials institute eyes bay area presence

Non-profit institute sees opportunities in licensing its technology to generate income to fund new equipment and facilities, CEO Fung says.

videocam
‘The priority is to commercialise our technology for local applications,’ NAMI CEO Andy Fung says. Photo: Handout
US-China relations

Opinion | Is biotech the next battleground in US-China decoupling?

With both countries viewing technological leadership as a zero-sum game, the risk of a fragmented global innovation ecosystem is growing.

videocam
Illustration: Craig Stephens
Hong Kong stock market

US bill targets Chinese biotechs Wuxi AppTec, Wuxi Biologics

Shares of Wuxi AppTec and Wuxi Biologics fell after the US House passed a bill that would restrict business with Chinese biotech companies.

US-China relations

‘China Week’ bill restricting US contracts with Chinese biotech firms among first to pass

The congressional chamber began voting Monday on a series of bills to limit Beijing’s political, economic and technological influence.

11
US-China relations

‘China week’ at US House puts biotech firms, Hong Kong offices in cross hairs

Most of the scheduled 28 items have bipartisan support and follow efforts to tackle national and economic security threats posed by Beijing.

videocam
19
Various pieces of US legislation intended to blunt China’s influence and competitive edge are soon due for consideration in Washington. Photo: Shutterstock
Science

Foreign buyouts of Chinese drug firms spark national security fears

Some industry figures warn that sanctions could limit Chinese patients’ access to vital drugs after a series of takeovers by international firms.

videocam
6
Some observers fear that selling Chinese firms to international companies could push up the cost of medicines domestically. Photo: Shutterstock
Health & Fitness

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

Research facility at the Hong Kong Science and Technology Park will conduct drug discovery in collaboration with university medical schools.

Technology

Hong Kong fund inks deal with biotech start-up as city aims for tech hub status

The Hong Kong Investment Corporation has struck a deal with a biotech firm started by Baidu founder Robin Li Yanhong, the fund’s second public move as the city seeks to boost its tech sector.

Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement